These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26364162)

  • 81. The NAD(P)H:quinone oxidoreductase I C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinoma.
    di Martino E; Hardie LJ; Wild CP; Gong YY; Olliver JR; Gough MD; Bird NC
    Genet Med; 2007 Jun; 9(6):341-7. PubMed ID: 17575500
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma.
    Paulson TG; Maley CC; Li X; Li H; Sanchez CA; Chao DL; Odze RD; Vaughan TL; Blount PL; Reid BJ
    Clin Cancer Res; 2009 May; 15(10):3305-14. PubMed ID: 19417022
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Unraveling the impact of irritability on esophageal diseases: Insights from multivariable Mendelian randomization analysis.
    Fang P; Zhou J; Liang Z; Yang Y; Luan S; Xiao X; Li X; Shang Q; Zhang H; Zeng X; Yuan Y
    J Affect Disord; 2024 Dec; 366():189-195. PubMed ID: 39187201
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Genomic regions associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study.
    Sun X; Chandar AK; Canto MI; Thota PN; Brock M; Shaheen NJ; Beer DG; Wang JS; Falk GW; Iyer PG; Abrams JA; Venkat-Ramani M; Veigl M; Miron A; Willis J; Patil DT; Nalbantoglu I; Guda K; Markowitz SD; Zhu X; Elston R; Chak A
    PLoS One; 2017; 12(10):e0184962. PubMed ID: 29073141
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Age-specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium.
    Drahos J; Xiao Q; Risch HA; Freedman ND; Abnet CC; Anderson LA; Bernstein L; Brown L; Chow WH; Gammon MD; Kamangar F; Liao LM; Murray LJ; Ward MH; Ye W; Wu AH; Vaughan TL; Whiteman DC; Cook MB
    Int J Cancer; 2016 Jan; 138(1):55-64. PubMed ID: 26175109
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON).
    Cook MB; Corley DA; Murray LJ; Liao LM; Kamangar F; Ye W; Gammon MD; Risch HA; Casson AG; Freedman ND; Chow WH; Wu AH; Bernstein L; Nyrén O; Pandeya N; Whiteman DC; Vaughan TL
    PLoS One; 2014; 9(7):e103508. PubMed ID: 25075959
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression.
    Li X; Galipeau PC; Sanchez CA; Blount PL; Maley CC; Arnaudo J; Peiffer DA; Pokholok D; Gunderson KL; Reid BJ
    Cancer Prev Res (Phila); 2008 Nov; 1(6):413-23. PubMed ID: 19138988
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Gene-Environment Interactions and the Risk of Barrett's Esophagus in Three US Cohorts.
    Crous-Bou M; Jovani M; De Vivo I; Jacobson BC
    Am J Gastroenterol; 2019 Jun; 114(6):893-899. PubMed ID: 30950840
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A risk variant for Barrett's esophagus and esophageal adenocarcinoma at chr8p23.1 affects enhancer activity and implicates multiple gene targets.
    Ali MW; Chen J; Yan L; Wang X; Dai JY; Vaughan TL; Casey G; Buas MF
    Hum Mol Genet; 2022 Nov; 31(23):3975-3986. PubMed ID: 35766871
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis.
    Bull LM; White DL; Bray M; Nurgalieva Z; El-Serag HB
    Dis Esophagus; 2009; 22(7):571-87. PubMed ID: 19222528
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma risk.
    Becker J; May A; Gerges C; Anders M; Schmidt C; Veits L; Noder T; Mayershofer R; Kreuser N; Manner H; Venerito M; Hofer JH; Lyros O; Ahlbrand CJ; Arras M; Hofer S; Heinrichs SK; Weise K; Hess T; Böhmer AC; Kosiol N; Kiesslich R; Izbicki JR; Hölscher AH; Bollschweiler E; Malfertheiner P; Lang H; Moehler M; Lorenz D; Ott K; Schmidt T; Nöthen MM; Hackelsberger A; Schumacher B; Pech O; Vashist Y; Vieth M; Weismüller J; Knapp M; Neuhaus H; Rösch T; Ell C; Gockel I; Schumacher J
    Cancer Med; 2016 May; 5(5):888-91. PubMed ID: 26783083
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Exploring the Impact of Antireflux Treatment on Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus: Insights from a Mendelian Randomization Study.
    Li Z; Yang K
    Gastroenterology; 2024 May; 166(5):944-945. PubMed ID: 38246505
    [No Abstract]   [Full Text] [Related]  

  • 93. Selenium, selenoenzymes, oxidative stress and risk of neoplastic progression from Barrett's esophagus: results from biomarkers and genetic variants.
    Takata Y; Kristal AR; Santella RM; King IB; Duggan DJ; Lampe JW; Rayman MP; Blount PL; Reid BJ; Vaughan TL; Peters U
    PLoS One; 2012; 7(6):e38612. PubMed ID: 22715394
    [TBL] [Abstract][Full Text] [Related]  

  • 94. eQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma.
    Wang X; Gharahkhani P; Levine DM; Fitzgerald RC; Gockel I; Corley DA; Risch HA; Bernstein L; Chow WH; Onstad L; Shaheen NJ; Lagergren J; Hardie LJ; Wu AH; Pharoah PDP; Liu G; Anderson LA; Iyer PG; Gammon MD; Caldas C; Ye W; Barr H; Moayyedi P; Harrison R; Watson RGP; Attwood S; Chegwidden L; Love SB; MacDonald D; deCaestecker J; Prenen H; Ott K; Moebus S; Venerito M; Lang H; Mayershofer R; Knapp M; Veits L; Gerges C; Weismüller J; Reeh M; Nöthen MM; Izbicki JR; Manner H; Neuhaus H; Rösch T; Böhmer AC; Hölscher AH; Anders M; Pech O; Schumacher B; Schmidt C; Schmidt T; Noder T; Lorenz D; Vieth M; May A; Hess T; Kreuser N; Becker J; Ell C; Tomlinson I; Palles C; Jankowski JA; Whiteman DC; MacGregor S; Schumacher J; Vaughan TL; Buas MF; Dai JY
    Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1735-1745. PubMed ID: 35709760
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Family History of Colorectal or Esophageal Cancer in Barrett's Esophagus and Potentially Explanatory Genetic Variants.
    Rubenstein JH; Tavakkoli A; Koeppe E; Ulintz P; Inadomi JM; Morgenstern H; Appelman H; Scheiman JM; Schoenfeld P; Metko V; Stoffel EM
    Clin Transl Gastroenterol; 2020 Apr; 11(4):e00151. PubMed ID: 32251017
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.
    Xie SH; Fang R; Huang M; Dai J; Thrift AP; Anderson LA; Chow WH; Bernstein L; Gammon MD; Risch HA; Shaheen NJ; Reid BJ; Wu AH; Iyer PG; Liu G; Corley DA; Whiteman DC; Caldas C; Pharoah PD; Hardie LJ; Fitzgerald RC; Shen H; Vaughan TL; Lagergren J
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2701-2709.e3. PubMed ID: 31756444
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Genome-wide DNA methylation profiling of cell-free serum DNA in esophageal adenocarcinoma and Barrett esophagus.
    Zhai R; Zhao Y; Su L; Cassidy L; Liu G; Christiani DC
    Neoplasia; 2012 Jan; 14(1):29-33. PubMed ID: 22355271
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Interactions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinoma.
    Zhai R; Chen F; Liu G; Su L; Kulke MH; Asomaning K; Lin X; Heist RS; Nishioka NS; Sheu CC; Wain JC; Christiani DC
    J Clin Oncol; 2010 May; 28(14):2445-51. PubMed ID: 20385987
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett's Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON Consortium.
    Lagergren K; Ek WE; Levine D; Chow WH; Bernstein L; Casson AG; Risch HA; Shaheen NJ; Bird NC; Reid BJ; Corley DA; Hardie LJ; Wu AH; Fitzgerald RC; Pharoah P; Caldas C; Romero Y; Vaughan TL; MacGregor S; Whiteman D; Westberg L; Nyren O; Lagergren J
    PLoS One; 2015; 10(9):e0138738. PubMed ID: 26406593
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Progressive dysbiosis of human orodigestive microbiota along the sequence of gastroesophageal reflux, Barrett's esophagus and esophageal adenocarcinoma.
    Hao Y; Karaoz U; Yang L; Yachimski PS; Tseng W; Nossa CW; Ye W; Tseng M; Poles M; Francois F; Traube M; Brown SM; Chen Y; Torralba M; Peek RM; Brodie EL; Pei Z
    Int J Cancer; 2022 Nov; 151(10):1703-1716. PubMed ID: 35751398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.